TRACER, NCT00527943 / 2006-002809-31: Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736) |
|
|
| Terminated | 3 | 12944 | NA | Vorapaxar, SCH 530348, MK-5348, Placebo | Merck Sharp & Dohme LLC, Duke Clinical Research Institute | Atherosclerosis, Myocardial Ischemia, Myocardial Infarction | 07/11 | 07/11 | | |